Diabetes complications

The insulin‐like growth factor system and the progression of renal complications of type 2 diabetes

Diabet MedPublished Prospective cohort study

Authors' conclusion

This longitudinal study indicated that higher baseline IGF-II, lower IGFBP-1 and higher IGFBP-2 are associated with a greater likelihood of albuminuria progression, independent of standard risk factors; lower IGBFP-1 also associated with greater increase in serum creatinine. Higher circulating IGFBP-2 level was also associated with relatively higher mortality. This study demonstrated the relevance of the IGF system to our understanding of renal complications in diabetes and strongly suggests that further exploration of mechanisms underlying these associations is merited.

Study context

Population
Individuals with T2D recruited from primary and secondary care (2002–2004), Salford and Manchester; 59.3% men, age 56.6 ± 9.4 years
Participants
436 individuals
Exposure
Baseline IGF/IGFBP profile and renal function trajectory
Outcome
Two primary outcomes: (i) change in urine ACR over time (ACR trend slope); (ii) change in serum creatinine over time (creatinine trend slope)
Follow-up
Up to 24 years
Methodological detailslongitudinal, follow-up up to 24 years
  • Longitudinal
  • Follow-up up to 24 years

Main finding

As reported in the abstract

mean follow-up 17.4 ± 5.2 years

Higher IGFBP-2 independently associated with faster albumin/creatinine ratio (ACR) progression (normalised beta)

Β = 0.007

p = 0.002

IGFBP-1 inverse association with ACR progression

B = −0.057

p = 0.009

IGF-II positively associated with ACR trend

B = 0.005

p = 0.013

IGFBP-1 inverse association with creatinine change, covariate-adjusted (unstandardised B)

B = −0.038

p = 0.04

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
All-cause mortality per 1 SD increase in IGFBP-2Cox proportional hazards; independent association1.306 (1.151–1.483)P = 0.0001

Original publication

The insulin‐like growth factor system and the progression of renal complications of type 2 diabetes. Diabet Med. Published 17 April 2026. doi:10.1111/dme.70318

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.